表紙SALE
市場調查報告書
商品編碼
1027945

Nutropix 市場預測、競爭趨勢、增長機會(~ 2026 年):按類型、產品類型、分銷渠道、用途、地區

Global Nootropics Market, By Type, By Product Type, By Distribution Channel, By Application, By Region, Competition Forecast & Opportunities, 2026

出版日期: | 出版商: TechSci Research | 英文 114 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

  • 全貌
  • 簡介
  • 目錄
簡介

在預測期內,全球 Nutropix 市場預計將以顯著的複合年增長率增長。

未來五年,支持大腦認知功能的藥物需求將激增,學生對激活大腦的藥物和智能藥物的需求將快速增長。預計將推動市場增長。另一方面,道德挑戰會抑制市場的進一步增長。

本報告調查了全球 Nutropix 市場,定義和概述了市場,分析了新型冠狀病毒感染 (COVID-19) 和其他市場影響因素,分析了客戶反饋和市場規模。它總結了趨勢/預測,按類型細分/產品類型/分銷渠道/用途,按地區/主要國家、競爭環境、市場份額、主要公司簡介等詳細分析。

目錄

第 1 章產品概述

第二章調查方法

第 3 章 COVID-19 的影響

第 4 章執行摘要

第五章客戶反饋

第 6 章世界市場展望

  • 市場規模/預測
  • 市場份額/預測
    • 按類型
      • 處方
      • 場外交易
    • 按產品類型
      • 自然
      • 綜合
    • 按分銷渠道
      • 在線
      • 離線
    • 按應用程序
      • 內存增強
      • 情緒/抑鬱
      • 注意力/專注
      • 長壽/抗衰老
      • 睡眠/恢復
      • 焦慮
      • 其他
    • 按地區
    • 按公司
  • 產品市場地圖

第七章北美市場分析與預測

  • 市場規模/預測
  • 市場份額/預測
    • 按類型
    • 按產品類型
    • 按分銷渠道
    • 按應用程序
    • 按國家/地區

第八章歐洲市場分析與預測

  • 市場規模/預測
  • 市場份額/預測
    • 按類型
    • 按產品類型
    • 按分銷渠道
    • 按應用程序
    • 按國家/地區

第九章亞太市場分析/預測

  • 市場規模/預測
  • 市場份額/預測
    • 按類型
    • 按產品類型
    • 按分銷渠道
    • 按應用程序
    • 按國家/地區

第10章南美市場分析/預測

  • 市場規模/預測
  • 市場份額/預測
    • 按類型
    • 按產品類型
    • 按分銷渠道
    • 按應用程序
    • 按國家/地區

第11章中東和非洲市場分析與預測

  • 市場規模/預測
  • 市場份額/預測
    • 按類型
    • 按產品類型
    • 按分銷渠道
    • 按應用程序
    • 按國家/地區

第 12 章市場動態

  • 促進因素
  • 挑戰

第 13 章市場趨勢

第14章競爭形勢

  • Accelerated Intelligence Inc.
  • AlternaScript LLC
  • Onnit Labs, Inc.
  • Peak Nootropics LLC
  • Teva Pharmaceutical Industries Ltd.
  • Purelife bioscience Co., Ltd
  • SupNootropic bio co., Ltd
  • Cephalon, Inc.
  • United Pharmacies(UK)Ltd.
  • Nootrobox Inc.(HVMN)

第15章 策略建議

第16章 關於出版商&免責事項

目錄
Product Code: 7749

Global nootropics market is projected to attain a significant growth in the forecast period, 2022-2026 with an impressive CAGR. The market growth can be attributed to the surging demand for the drugs and pharmaceuticals that support the brain's cognitive functions. Moreover, the rapidly increasing demand for brain boosters and smart drugs among the student population is driving the growth of the global nootropics market in the upcoming five years. The students are inclined toward nootropics as these improve cognitive function, such as executive functions, memory, creativity, or motivation. The rising awareness about these drugs is supporting the growth of the global nootropics market in the next five years. Although the ethical issues regarding the use of nootropics drugs by the healthy individual may put some restraint over the growth of the global nootropics market in future. In the year, 2019 the United States Food and Drug Administration and Federal Trade Commission warned the manufacturers and market players involved in the advertisements, about the probable advertisement fraud and marketing scams related to nootropics substances. The issue of substance abuse is also a major concern regarding the drug, although regulatory sales and prospective warnings are anticipated to support the future growth of the global nootropics market in the future five years of forecast, until 2026.

Nootropics are the drugs, supplements and related components that are expected to work efficiently in increasing and enhancing brain activities like cognitive thinking, executive functioning of the brain, higher memory retention, and creating senses of healthy motivation for the individuals. Patients suffering from mood swings, depression, lack of attention and focus, and sleep disorders are often prescribed nootropics for their recovery. Nootropics are often associated with the term "smart drugs" for their functions and effect on the patients.

The global nootropics market is segmented by type, product type, distribution channel, application, regional distribution, and competitional analysis. Based on type, the market is further bifurcated into prescription and over the counter nootropics drugs. Prescription nootropics are anticipated to hold the largest revenue share of the market and assert their dominance over the market in the upcoming five years on account of rapidly increasing cases of depression, mood swings, anxiety and stress. The patients suffering from such mental health issues are able to control their symptoms these drugs as these help them to facilitate their thoughts. Also, concerned legalities and ethical issues have made it essential for the prescription to be produced to purchase the nootropics thereby supporting the growth of the global nootropics market in the next five years.

Holding the major shares of the global nootropics market are Accelerated Intelligence Inc., AlternaScript LLC, Onnit Labs, Inc., Peak Nootropics LLC, Teva Pharmaceutical Industries Ltd., Purelife bioscience Co., Ltd, SupNootropic bio co., Ltd, Cephalon, Inc., United Pharmacies (UK) Ltd., Nootrobox Inc. (HVMN), among others. Market players are actively involved in the research and product development. The advanced technology has made it possible for the industry to provide excellent services through nootropics drugs. Further advancement would aid the market value and brand establishment in the future five years. New market players may focus on the research and development to provide options that satisfies the demand as well as benefits the market players in building their brand value. Other competitive strategies include mergers & acquisitions and new product developments.

Years considered for this report:

  • Historical Years: 2016 - 2019
  • Base Year: 2020
  • Estimated Year: 2021
  • Forecast Period: 2022 - 2026

Objective of the Study:

  • To analyze the historical growth in the market size of global nootropics market from 2016 to 2020.
  • To estimate and forecast the market size of global nootropics market from 2021 to 2026 and growth rate until 2026.
  • To classify and forecast global nootropics market based on type, product type, distribution channel, application, competitional landscape, and regional distribution.
  • To identify dominant region or segment in the global nootropics market.
  • To identify drivers and challenges for global nootropics market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global nootropics market.
  • To identify and analyze the profile of leading players operating in global nootropics market.
  • To identify key sustainable strategies adopted by market players in global nootropics market.

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of manufacturers, suppliers, and distributors across the global. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufactures which could not be identified due to the limitations of secondary research. TechSci Research analyzed the manufactures, distribution channels and presence of all major players across the globe.

TechSci Research calculated the market size of global nootropics market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

  • Manufacturers, end users, and other stakeholders
  • Distributors and suppliers of nootropics and other stakeholders
  • Organizations, forums, and alliances related to nootropics
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, suppliers, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, global nootropics market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

Global Nootropics Market, By Type:

  • Prescription
  • Over the Counter

Global Nootropics Market, By Product Type:

  • Natural
  • Synthetic

Global Nootropics Market, By Distribution Channel:

  • Online
  • Offline

Global Nootropics Market, By Application:

  • Memory Enhancement
  • Mood & Depression
  • Attention & Focus
  • Longevity & Anti-aging
  • Sleep & Recovery
  • Anxiety
  • Others

Global Nootropics Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait
  • South America
    • Brazil
    • Argentina
    • Colombia

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global nootropics market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Impact of COVID-19 on Global Nootropics Market

4. Voice of Customer

5. Executive Summary

6. Global Nootropics Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type (Prescription v/s Over the Counter)
    • 6.2.2. By Product Type (Natural v/s Synthetic)
    • 6.2.3. By Distribution Channel (Online v/s Offline)
    • 6.2.4. By Application (Memory Enhancement, Mood & Depression, Attention & Focus, Longevity & Anti-aging, Sleep & Recovery, Anxiety, Others)
    • 6.2.5. By Region
    • 6.2.6. By Company (2020)
  • 6.3. Product Market Map

7. North America Nootropics Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By Product Type
    • 7.2.3. By Distribution Channel
    • 7.2.4. By Application
    • 7.2.5. By Country
  • 7.3. North America: Country Analysis
    • 7.3.1. United States Nootropics Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By Product Type
        • 7.3.1.2.3. By Distribution Channel
        • 7.3.1.2.4. By Application
    • 7.3.2. Mexico Nootropics Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By Product Type
        • 7.3.2.2.3. By Distribution Channel
        • 7.3.2.2.4. By Application
    • 7.3.3. Canada Nootropics Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By Product Type
        • 7.3.3.2.3. By Distribution Channel
        • 7.3.3.2.4. By Application

8. Europe Nootropics Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By Product Type
    • 8.2.3. By Distribution Channel
    • 8.2.4. By Application
    • 8.2.5. By Country
  • 8.3. Europe: Country Analysis
    • 8.3.1. France Nootropics Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By Product Type
        • 8.3.1.2.3. By Distribution Channel
        • 8.3.1.2.4. By Application
    • 8.3.2. United Kingdom Nootropics Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By Product Type
        • 8.3.2.2.3. By Distribution Channel
        • 8.3.2.2.4. By Application
    • 8.3.3. Italy Nootropics Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By Product Type
        • 8.3.3.2.3. By Distribution Channel
        • 8.3.3.2.4. By Application
    • 8.3.4. Germany Nootropics Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
        • 8.3.4.2.2. By Product Type
        • 8.3.4.2.3. By Distribution Channel
        • 8.3.4.2.4. By Application
    • 8.3.5. Spain Nootropics Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type
        • 8.3.5.2.2. By Product Type
        • 8.3.5.2.3. By Distribution Channel
        • 8.3.5.2.4. By Application

9. Asia-Pacific Nootropics Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By Product Type
    • 9.2.3. By Distribution Channel
    • 9.2.4. By Application
    • 9.2.5. By Country
  • 9.3. Asia-Pacific: Country Analysis
    • 9.3.1. China Nootropics Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By Product Type
        • 9.3.1.2.3. By Distribution Channel
        • 9.3.1.2.4. By Application
    • 9.3.2. India Nootropics Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By Product Type
        • 9.3.2.2.3. By Distribution Channel
        • 9.3.2.2.4. By Application
    • 9.3.3. Japan Nootropics Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By Product Type
        • 9.3.3.2.3. By Distribution Channel
        • 9.3.3.2.4. By Application
    • 9.3.4. Australia Nootropics Market Outlook
      • 9.3.4.1. Market Size & Forecast
        • 9.3.4.1.1. By Value
      • 9.3.4.2. Market Share & Forecast
        • 9.3.4.2.1. By Type
        • 9.3.4.2.2. By Product Type
        • 9.3.4.2.3. By Distribution Channel
        • 9.3.4.2.4. By Application
    • 9.3.5. South Korea Nootropics Market Outlook
      • 9.3.5.1. Market Size & Forecast
        • 9.3.5.1.1. By Value
      • 9.3.5.2. Market Share & Forecast
        • 9.3.5.2.1. By Type
        • 9.3.5.2.2. By Product Type
        • 9.3.5.2.3. By Distribution Channel
        • 9.3.5.2.4. By Application

10. South America Nootropics Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type
    • 10.2.2. By Product Type
    • 10.2.3. By Distribution Channel
    • 10.2.4. By Application
    • 10.2.5. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Nootropics Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By Product Type
        • 10.3.1.2.3. By Distribution Channel
        • 10.3.1.2.4. By Application
    • 10.3.2. Argentina Nootropics Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By Product Type
        • 10.3.2.2.3. By Distribution Channel
        • 10.3.2.2.4. By Application
    • 10.3.3. Colombia Nootropics Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By Product Type
        • 10.3.3.2.3. By Distribution Channel
        • 10.3.3.2.4. By Application

11. Middle East and Africa Nootropics Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value
  • 11.2. Market Share & Forecast
    • 11.2.1. By Type
    • 11.2.2. By Product Type
    • 11.2.3. By Distribution Channel
    • 11.2.4. By Application
    • 11.2.5. By Country
  • 11.3. MEA: Country Analysis
    • 11.3.1. South Africa Nootropics Market Outlook
      • 11.3.1.1. Market Size & Forecast
        • 11.3.1.1.1. By Value
      • 11.3.1.2. Market Share & Forecast
        • 11.3.1.2.1. By Type
        • 11.3.1.2.2. By Product Type
        • 11.3.1.2.3. By Distribution Channel
        • 11.3.1.2.4. By Application
    • 11.3.2. UAE Nootropics Market Outlook
      • 11.3.2.1. Market Size & Forecast
        • 11.3.2.1.1. By Value
      • 11.3.2.2. Market Share & Forecast
        • 11.3.2.2.1. By Type
        • 11.3.2.2.2. By Product Type
        • 11.3.2.2.3. By Distribution Channel
        • 11.3.2.2.4. By Application
    • 11.3.3. Saudi Arabia Nootropics Market Outlook
      • 11.3.3.1. Market Size & Forecast
        • 11.3.3.1.1. By Value
      • 11.3.3.2. Market Share & Forecast
        • 11.3.3.2.1. By Type
        • 11.3.3.2.2. By Product Type
        • 11.3.3.2.3. By Distribution Channel
        • 11.3.3.2.4. By Application
    • 11.3.4. Kuwait Nootropics Market Outlook
      • 11.3.4.1. Market Size & Forecast
        • 11.3.4.1.1. By Value
      • 11.3.4.2. Market Share & Forecast
        • 11.3.4.2.1. By Type
        • 11.3.4.2.2. By Product Type
        • 11.3.4.2.3. By Distribution Channel
        • 11.3.4.2.4. By Application

12. Market Dynamics

  • 12.1. Drivers
  • 12.2. Challenges

13. Market Trends & Developments

14. Competitive Landscape

  • 14.1. Accelerated Intelligence Inc.
  • 14.2. AlternaScript LLC
  • 14.3. Onnit Labs, Inc.
  • 14.4. Peak Nootropics LLC
  • 14.5. Teva Pharmaceutical Industries Ltd.
  • 14.6. Purelife bioscience Co., Ltd
  • 14.7. SupNootropic bio co., Ltd
  • 14.8. Cephalon, Inc.
  • 14.9. United Pharmacies (UK) Ltd.
  • 14.10. Nootrobox Inc. (HVMN)

15. Strategic Recommendations

16. About Us & Disclaimer